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Background Modern molecular techniques reveal new
information on the role of respiratory viruses in
community-acquired pneumonia. In this study, we tried to
determine the prevalence of respiratory viruses and bacteria in
patients with community-acquired pneumonia who were admitted
to the hospital.
Methods Between April 2008 and April 2009, 408 adult
patients (aged between 20 and 94 years) with
community-acquired pneumonia were tested for the presence
of respiratory pathogens using bacterial cultures, real-time PCR
for viruses and bacteria, urinary antigen testing for Legionella and
Pneumococci and serology for the presence of viral and bacterial
pathogens.
Results Pathogens were identified in 263 (64Æ5%) of the 408
patients. The most common single organisms in these 263 patients
were Streptococcus pneumoniae (22Æ8%), Coxiella burnetii (6Æ8%)
and influenza A virus (3Æ8%). Of the 263 patients detected with
pathogens, 117 (44Æ5%) patients were positive for one or more viral
pathogens. Of these 117 patients, 52 (44Æ4%) had no bacterial
pathogen. Multiple virus infections (‡2) were found in 16 patients.
Conclusion In conclusion, respiratory viruses are frequently
found in patients with CAP and may therefore play an important
role in the aetiology of this disease.
Keywords Adults, aetiology, community-acquired pneumonia,
respiratory virus infection, viral.
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Introduction
Community-acquired pneumonia (CAP) is a common
disorder and a major medical problem. In 30–50% of the
patients with CAP, no specific organism is identified,
despite the extensive use of diagnostic tests.1–3 The most
common causative pathogen of bacterial CAP is Streptococ-
cus pneumoniae.4 Mycoplasma pneumoniae and Chlamydo-
phila pneumoniae are among the most common ‘atypical’
pathogens.
Potential viral causes of CAP are often not explored
because of the lack of antiviral agents and the relative unfa-
miliarity with viral pneumonia. However, it is well known
that viral infections of the respiratory tract are the cause
for significant mortality and morbidity all over the world,
particularly in children and elderly adults.
Viral respiratory pathogens that are commonly found
include rhinoviruses, coronaviruses, influenza viruses,
respiratory syncytial viruses, parainfluenza viruses and
adenoviruses. Over the past decade, analysis of clinical
specimens of the respiratory tract through different diag-
nostic methods have led to the discovery of new viruses,
such as human metapneumovirus,9 human severe acute
respiratory syndrome coronavirus,10 coronaviruses NL6311
and HKU1,12 human bocavirus13 and the recently described
polyomaviruses KIPyV14 and WUPyV.15
In this study, we tried to reveal the aetiology of commu-
nity-acquired pneumonia in patients admitted to the hospi-
tal with community-acquired pneumonia using extensive
molecular testing for viral and bacterial pathogens.
Materials and methods
From April 2008 through March 2009, we analysed all the
patients aged 18 years and older who presented at the
emergency ward of the St Elisabeth Hospital, Tilburg, or
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Community-acquired pneumonia was defined as suspi-
cion of acute respiratory tract infection with a new or pro-
gressive infiltrate on a chest radiograph and one of the
following criteria: fever (temperature ‡38Æ0C) or hypother-
mia (temperature <35C), new cough with or without spu-
tum production, abnormal percussion and altered breath
sounds on auscultation, dyspnoea or tachypnea or hypoxia,
and leucocytosis or leucopenia.
We excluded patients with recent hospitalization
(<2 weeks) and those residing in long-term care facilities,
patients with known bronchial obstruction or a history of
post-obstructive pneumonia other than COPD, patients
with primary lung cancer or another malignancy metastatic
to the lungs, and patients with AIDS, patients with known
or suspected Pneumocystis jirovecii pneumonia or patients
with known or suspected active tuberculosis. The study was
approved by the local medical ethics committee. Written
informed consent was obtained from all participants in the
study.
Samples
At the emergency ward a throat swab was taken, and two
sets of blood samples were obtained and cultured according
to standard microbiological procedures. If available, a spu-
tum sample was evaluated by use of Gram staining and
culture.
Urinary antigen detection tests for Streptococcus pneumo-
niae and Legionella pneumophila were performed with the
BinaxNOW pneumococcal urinary antigen test and the
BinaxNOWLegionella urinary antigen test (both from
Binax, ME, USA). Paired serum samples were obtained
during the acute and convalescent phases of infection
(separated by at least 2 weeks) for serological studies.
A case report form was obtained for every patient.
Molecular detection of respiratory pathogens
All samples were tested using real-time PCR for the pres-
ence of respiratory viruses and bacteria including adenovi-
rus (AdV), human bocavirus (hBoV), KI- and WU
polyomaviruses (KIPyV and WUPyV), human metapneu-
movirus (hMPV), human rhinovirus (HRV), human coro-
naviruses (HCoV) (OC43, NL63, HKU and 229E),
parainfluenza viruses (PIV),1–4 influenza viruses A and B
(InfA, InfB), respiratory syncytial virus (RSV), Legionella
pneumophila, Mycoplasma pneumoniae, Chlamydophila
psittaci, Chlamydophila pneumoniae, Coxiella burnetii and
Streptococcus pneumoniae. Real-time PCR procedures
were performed as described in reference 16–22. Briefly,
nucleic acids were extracted from the throat swabs with the
MagNa pure LC using the total nucleic acid isolation kit
system according to the manufacturer’s protocol (Roche
Diagnostics, Basel, Switzerland). Each sample was eluted in
1000 ll of buffer sufficient to perform all the real-time
PCRs. cDNA was synthesized by using MultiScribe reverse
transcriptase (RT) and random hexamers (both from
Applied Biosystems, Carlsbad, CA, USA). The reaction was
performed in 100 ll of reaction mixture consisting of 10 ll
RT-buffer (10·), 22 ll MgCl2 (25 mm), 20 ll dNTP-mix
(10 mm), 5 ll random hexameer (50 lm), 2,5 ll Multi-
Scribe RT (50 U ⁄ll), 2 ll Rnase inhibitor (20 U ⁄ll) (EZ
RT-PCR kit; Applied Biosystems) and 40 ll of the isolated
sample. After incubation for 10 minutes at 25C, RT was
carried out for 30 minutes at 48C, followed by RT inacti-
vation for 5 minutes at 95C.
Classification of aetiology
An aetiological agent for CAP was considered present, if
any of the following criteria were met: a pathogenic micro-
organism was cultured from blood samples; the urinary
antigen test was positive for S. pneumoniae or L. pneumo-
phila; PCR of the throat swab or sputum samples yielded a
positive result; sputum samples (presence of >25 polymor-
phonuclear leucocytes and <10 squamous cells per field)
with a predominant organism and compatible results from
Gram stain; the presence of IgM antibodies for M. pneumo-
niae, or a fourfold increase in IgG antibody titres for
M. pneumoniae, L. pneumophila, Chlamydophila psittaci and
Coxiella burnetii.
Statistical analysis
Groups were compared by a chi-squared test with a signifi-
cance level of P < 0Æ05. Analyses were conducted using
PASW Statistics 18 (IBM Company, Chicago, IL, USA).
Results
From April 2008 through March 2009, 408 patients were
included. The demographic characteristics of the patients
are presented in Table 1. Patients ranged in age from 20 to
94 years (mean 65 years; median 68 years), 61Æ3% of the
patients were men and 38Æ7% were women.
Of the 408 patients, we collected 408 throat swabs, 408
pneumococcal urinary antigen tests, 405 legionella urinary
antigen tests, 203 sputum samples for bacterial culture, 163
sputum samples for molecular detection, 329 blood
cultures, 90 serum samples for M. pneumoniae, 66 serum
samples for L. pneumophila, 44 serum samples for
Chlamydophila psittaci and 104 serum samples for Coxiella
burnetii. All samples were taken from unique patients, that
is, none of the patients had duplicate samples taken.
Aetiology
Aetiology was identified in 263 (64Æ5%) of the 408 patients,
and more than one pathogen was isolated in 106 patients
(26Æ0%). Results are shown in Table 2. Of the 263
patients identified with a pathogen, 117 (28Æ7%) patients
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were positive for one or more viral pathogens. A bacterial
pathogen was detected in 65 (55Æ5%) of these 117 patients,
whereas in 52 (44Æ4%) of these patients, only respiratory
viruses were detected. S. pneumoniae, Coxiella burnetii and
InfA were identified as the only micro-organism in 22Æ8%,
6Æ8% and 3Æ8% of the 263 patients, respectively.
In 139 patients with CAP, S. pneumoniae was detected.
In 60 (43Æ2%) patients, S. pneumoniae was the only identi-
fiable pathogen. Of those 60 patients, 17 were diagnosed by
the urinary antigen assay alone, 14 were only detected by
culture or molecular detection of S. pneumoniae in sputum
samples and six had only positive blood cultures. In addi-
tion, in five patients, both blood culture and the urinary
antigen test were positive, in three patients both blood cul-
ture and sputum samples were positive, in seven patients
sputum samples and the urinary antigen test were positive
and in eight patient all three tests were positive. Of the
remaining 79 S. pneumoniae patients having other patho-
gens as well, 11 patients had only a positive urinary antigen
assay, and 53 patients had a positive PCR from sputum,
two patients had only a positive blood culture and urinary
antigen test, three patients had a positive blood culture and
a positive PCR from sputum samples and nine patients
had a positive PCR from the sputum sample and a
positive urinary antigen test. In 53 patients diagnosed with
pneumococcal CAP, the following viruses were found:
HRV 19 times, InfA 11 times, HCoV OC43 eight times,
PIV1 seven times. RSV, HCoV 229E three times, hMPV,
HCoV NL63, and InfB all two times and KIPyV, WUPyV
and hBoV were each detected one time.
Haemophilus influenzae was found in 21 of the 203 spu-
tum samples and in one blood culture. In 11 of these
patients, one or more respiratory viruses were detected as
well. HRV was detected three times, PIV1, InfA, HCoV
OC43 and RSV were each detected two times, and hBoV,
KIPyV and WUPyV were each detected one time.
Statistical analysis showed a significant association
between patients with H. influenzae and viral pathogens
(P = 0Æ023) and a significant association between patients
with S. pneumoniae and viral pathogens (P = 0Æ003).
Legionella was found in 15 patients. Of two patients the
legionella urinary antigen tests, serum samples and respira-
tory samples were positive for L. pneumophila. Three
patients had a positive legionella urinary antigen test and
positive respiratory sample, in four patients only the
urinary antigen test was positive, in three patients only the
respiratory sample and in one patient only the serum
samples for L. pneumophila were positive.
Mycoplasma pneumoniae-specific IgM was found in only
one of the 90 patients tested, and in two respiratory
samples, M. pneumoniae DNA was detected.
Coxiella burnetii, causing Q fever, was found in 37
patients (in 12 serum samples and in 25 respiratory sam-
ples). Chlamydophila psittaci was found in seven patients
and Chlamydophila pneumoniae was found in two patients.
In total, 117 (28Æ7%; 69 male and 48 female) of the 408
patients were positive for one or more viral pathogens.
There was no significant difference between viruses infect-
ing men and women. All common respiratory viruses were
detected. HRV was detected at the highest frequency, in 34
(8Æ3%) of the 408 patients. The detection rates for the
other viruses were 5Æ6% for InfA, 4Æ4% for PIV1, 2Æ9% for
HCoV OC43, 2Æ2% for InfB, 2Æ0% for RSV, 1Æ5% for
HCoV NL63, 1Æ2% for PIV3 and HCoV 229E. For hMPV,
PIV 2, HCoV HKU, hBoV, KIPyV, WUPyV and AdV, the
detection rates were <1%. PIV4 was not detected.
Co-detection of respiratory viruses
In the 117 virus-positive patients, a total of 136 viruses
were detected. Multiple virus infections (‡2) were found in
16 patients (Table 3). Thirteen (3Æ2%) of the 408 patients
had two respiratory viruses and 3 (0Æ7%) patients had three
viruses present in their respiratory samples. PIVs were the
most frequently found viral agents in the multiple infected
patients and were found in eight patients [PIV 1 (six
times), PIV 2 (one time), PIV 3 (three times)], followed by
coronaviruses in seven patients [HKU (one time), OC43
(two times), 229E (one time), NL63 (four times)] and InfB
in four patients, InfA in three patients. HRVs, hBoV, RSV,
KIPyV and WUPyV were co-detected in two patients.











Comorbidity – no. (%)
Chronic Obstructive Pulmonary Disease 131 (32Æ1)
Liver disease 2 (0Æ5)
Cardiac failure 88 (21Æ6)
Cerebrovascular disease 35 (8Æ6)
Diabetes mellitus 78 (19Æ1)
Renal insufficiency 12 (2Æ9)
Malignancy 46 (11Æ3)
Immunodeficiency
Suspicion or proven immunodeficiency 9 (2Æ2)
Immunosuppressive therapy
>10 mg prednisone 48 (11Æ8)
Other 11 (2Æ7)
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Seasonality and frequency of respiratory viruses
The period of the year in which viruses were detected var-
ied per virus as presented in Figure 1. Whereas InfA had
one major peak lasting from January to February 2009,
InfB was detected throughout the whole study period be it
at a low rate. Also HRVs were found during the entire
year, although a small peak was observed in May ⁄ June
2008. RSV was detected only from November 2008 to
January 2009 and hMPV from January 2009 to March
2009. HCoV OC43 the most detected coronavirus peaked
in December 2008.
Discussion
This study revealed the viral and bacterial aetiology in 263
(64Æ5%) of 408 patients with community-acquired pneumo-
nia. In spite of using sputum samples, blood cultures, urine
for antigen assays, throat swabs and serum samples, no caus-
ative agent was found in  35% of the subjects. This is in line
with the literature, where levels of identification of the causa-
tive micro-organisms in CAP vary from 46% to 83%. This
variation is attributable to differences in detection techniques
and in selection of patients who are included. We improved
the yield by testing sputum samples for S. pneumoniae,
Mycoplasma pneumoniae, Chlamydophila pneumoniae,
Chlamydophila psittaci and L. pneumophila.
We identified S. pneumoniae (22Æ8%) as the most com-
mon single organism in 263 patients, followed by Coxiella
burnetii (6Æ8%) and influenza A virus (3Æ8%). This was
similar to other studies, which also reported S. pneumoniae
as a predominant causative agent.1
On the other hand, we did not find many Mycoplasma
pneumoniae infections in our study, even though in the lit-
erature M. pneumoniae is among the most common ‘atypi-
cal’ pathogens. This might be due to the fact that
M. pneumoniae infections occur in cyclic epidemics every
3–5 years and infections are generally mild. Many adult
cases may be asymptomatic and not in need of medical
attention.25 In the Netherlands, CAP affects about 5–10
persons per 1000 inhabitants, and only 5–20% of these
Table 2. Aetiology of CAP in the patients by material
Bloodcultures (n = 329) Sputa  Molecular diagnostics Throat swabs
No growth 286 (86.9%) Viruses (n = 163) Viruses (n = 408)
Haemophilus influenzae 1 (0.3%) Adenovirus 1 (0.6%) Adenovirus 3 (0.7%)
Streptococcus pneumoniae 28 (8.6%) Human bocavirus 0 Human bocavirus 3 (0.7%)
Staphylococcus aureus 1 (0.3%) KI polyomavirus 0 KI polyomavirus 2 (0.5%)
Pseudomonas aeruginosa 2 (0.6%) WU polyomavirus 1 (0.6%) WU polyomavirus 3 (0.7%)
Escherichia coli 3 (0.9%) Human metapneumovirus 1 (0.6%) Human metapneumovirus 3 (0.7%)
Other 8 (2.4%) Human rhinovirus 24 (14.7%) Human rhinovirus 19 (4.7%)
Pneumococcal urinary
antigen test (n = 408)
Human coronaviruses Human coronaviruses
Positive 60 (14.7%) OC43 8 (4.9%) OC43 12 (2.9%)
Negative 348 (85.3%) NL63 2 (1.2%) NL63 5 (1.2%)
Legionella urinary
antigen test (n= 405)
HKU 0 HKU 1 (0.2%)
Positive 9 (2.2%) 229E 0 229E 5 (1.2%)
Negative 396 (97.8%) Parainfluenza viruses Parainfluenza viruses
Serology 1 1 (0.6%) 1 17 (4.2%)
Legionella pneumophila 3 (n = 66) 2 0 2 1 (0.2%)
Mycoplasma pneumoniae 1 (n = 90) 3 3 (1.8%) 3 3 (0.7%)
Coxiella burnetii 12 (n = 104) 4 0 4 0
Chlamydophila psittaci 4 (n = 44) Influenza A virus 8 (4.9%) Influenza A virus 23 (5.6%)
Influenza B virus 1 (0.6%) Influenza B virus 9 (2.2%)
Sputa  Culture (n = 203) Respiratory syncytial virus 4 (2.5%) Respiratory syncytial virus 5 (1.2%)
No growth 8 (3.9%)
No pathogens 137 (67.5%) Bacteria (n = 167) Bacteria (n = 408)
Haemophilus influenzae 21 (10.3%) Legionella pneumophila 8 (4.8%) Legionella pneumophila 3 (0.7%)
Streptococcus pneumoniae 7 (3.5%) Mycoplasma pneumoniae 2 (1.2%) Mycoplasma pneumoniae 2 (0.5%)
Staphylococcus aureus 8 (3.9%) Coxiella burnetii 17 (10.2%) Coxiella burnetii 16 (3.9%)
Pseudomonas aeruginosa 3 (1.5%) Chlamydophila psittaci 4 (2.4%) Chlamydophila psittaci 0
Moraxella catarrhalis 4 (2.0%) Chlamydophila pneumoniae 0 Chlamydophila pneumoniae 2 (0.5%)
Escherichia coli 2 (1.0%)
Gram-negative bacilli 13 (6.4%) Streptococcus pneumoniae 97 (57.4%; n = 169)
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cases are admitted to hospitals. Furthermore, the distribu-
tion of pathogens causing CAP may vary by country, owing
to geographic differences.
In our study, Chlamydophila pneumoniae was detected in
throat samples of two patients only. Some studies indicated
C. pneumoniae as one of the most common ‘atypical’
pathogens. However, a recent study by Wellinghausen
et al.,29 found a low prevalence (<1%) of C. pneumonia
which is in accordance with our findings. It is unclear what
the reasons are for these different detection rates.
The most important limitation in our study was that we
did not include a control group to determine the preva-
lence of viral respiratory pathogens and bacterial patho-
gens. In a case–control study by van Gageldonk-Lafeber
et al.,30 the incidence and aetiology of acute respiratory
tract infections in patients visiting their general practitio-
ners was studied and the researchers detected pathogens,
mostly viruses, in approximately 30% of the subjects with
no respiratory complaints. Another limitation was the
incomplete sputum sample collection. The reason was the
inability of patients to produce sputum. Therefore, throat
swabs were taken of all patients. As the sensitivity of throat
swabs may be lower than the sensitivity of sputum, naso-
pharyngeal sampling or washings, it is possible that we
underestimated the prevalence of viruses in our population.
Respiratory viruses were found as the only detectable
pathogen in 52 patients who had been included throughout
the year, covering all the seasons. Year-round inclusion is
important to cover the complete spectrum of respiratory
virus infections, because several viruses are known to be
found only in particular months of the year.
InfA has been found as the second most frequent pathogen
in CAP patients and the most common viral pathogen in all
the age groups. In adults, InfA, RSV, rhinoviruses and ade-
noviruses are recognized as important causes for CAP.32
However, viruses that cause community-acquired pneumo-
nia are often overlooked by clinicians. It still remains unclear
whether some respiratory virus can cause pneumonia by
itself or whether it needs the help of other respiratory patho-
gens. In our study, viral and bacterial pathogens were found
in 65 (16%) patients. Co-infection rates have been described
in 5Æ7–22Æ5% of CAP in other studies. The most common
bacterial co-pathogens were H. influenzae and S. pneumo-
niae. In agreement with other studies, we found an associa-
tion between S. pneumoniae and viruses. We also found an
association between H. influenzae and viruses.
In general, blood samples for bacterial culture are rela-
tively easily obtainable, and if positive, they provide a
microbiological diagnosis. In our study, 13Æ1% of the blood
cultures revealed a pathogen, which is similar to the results
of other studies.
In the literature, S. pneumoniae PCR on sputum samples
as a diagnostic tool for pneumococcal disease has had
mixed results because distinguishing colonization from
infection using S. pneumoniae PCR is difficult even by
quantifying the load.35–38 Culture has important limitations
as well. Prior antibiotic therapy is of great influence on the
growth of S. pneumoniae in sputum samples and blood cul-
tures. Several studies found that during antibiotic treatment
sputum samples became rapidly negative for S. pneumoniae
in contrast to the S. pneumoniae PCR that remained posi-
tive. In our study, S. pneumoniae was detected in all cul-
ture-positive sputum samples and in many culture-negative
sputum samples by PCR, presumably reflecting the
increased sensitivity of molecular technique above tradi-
tional culture methods. Of the 60 patients with S. pneumo-
niae as causative organism, the pneumococcal antigen assay
was positive in 62%. The results of the pneumococcal
antigen assay showed a lower sensitivity compared with
data reported by others.42 The reason for this difference in
Table 3. Positive patients with multiple viruses
Patients






















+ Parainfluenza virus 1
7 Parainfluenza
virus 3



















+ Influenza B virus
13 Influenza A virus + Influenza B virus
14 Influenza A virus + WU polyomavirus
15 Influenza A virus + Parainfluenza virus 1
16 Influenza B virus + KI polyomavirus
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sensitivity is unclear but could be explained by the influ-
ence of prior antibiotic therapy, not concentrating the
urine before executing the assay, and the fact that the
pneumococcal antigen assay is more sensitive in patients
who are bacteraemic than in patients without a bactera-
emia.
Legionella pneumophila was diagnosed in 15 cases
(3Æ8%), which is in agreement with results obtained by
previous studies.44
Finally, in our study population, a relatively large num-
ber of CAP cases were caused by Coxiella burnetii. This was
owing to a Q fever outbreak in our area with over 4000
notified cases in the Netherlands between 2007 and 2010.45
Conclusions
In 408 adult patients presenting at the hospital with CAP,
a pathogen was demonstrated in 64Æ5%. S. pneumoniae,
influenza A virus and Coxiella burnetii were the three most
frequent pathogens. Mixed viral and bacterial infections
were frequently observed, and in 29% of the patients with
CAP, a virus was detected, including 13% of the patients in
which only viruses were detected. Further investigations are
warranted to elucidate the importance of viruses as
causative agents in the pathogenesis of CAP in adult
patients.
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